06/22/2022 | Press release | Distributed by Public on 06/22/2022 19:43
[WASHINGTON, D.C.] - U.S. Senator Tammy Duckworth (D-IL), member of the U.S. Committee on Commerce, Science & Transportation, issued the following statement after the bipartisan Pharmacy Benefit Manager Transparency Act passed out of committee by a vote of 19-9:
"I was proud to join my colleagues on both sides of the aisle in supporting the passage of the bipartisan Pharmacy Benefit Manager Transparency Act out of committee. While there is still much work to be done to make drugs more affordable for hardworking Americans, including capping out-of-pocket costs for medicines like insulin and allowing Medicare to negotiate drug prices, this bill is an important step in lowering drug costs for millions. I hope the Congress can move quickly to send it to President Biden's desk."
Specifically, the Pharmacy Benefit Manager Transparency Act would:
Duckworth supports lowering the cost of healthcare and prescription drugs for working Americans. This week, she voiced her support for the bipartisan INSULIN Act. In March, she joined U.S. Senator Reverend Raphael Warnock (D-GA) to introduce the Affordable Insulin Now Act, which would require Medicare plans and private group or individual plans to cap patients' out-of-pocket costs for insulin at $35 per month.
-30-